F773 in New Mexico. Pick another state for the same tag.
Against expectation — 2023
New Mexico cites F773 more often than its own record predicts
Versus expected share1.07×
1.07 times the share F773 takes of citations nationally.
Share of New Mexico citations0.12%
Of every deficiency written in New Mexico in 2023, this is the portion that was F773.
New Mexico0.12%
National0.11%
Share of all citations that were F773.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New Mexico surveyors wrote
F773 findings written in New Mexico, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedDecember 1, 2023
Based on interview and record review, the facility failed to ensure lab work (a process of collecting blood samples to determine therapeutic levels of medication is the body) was completed as ordered by the physician for 1 (R #194) of 1 (R # 194) residents randomly sampled. This deficient practice of not obtaining lab work could result in health concerns not being addressed timely and can cause health problems such as a Vancomycin Trough level (Peak and trough levels are usually monitored, Toxicity is best monitored by looking at lab values) toxicity to go unidentified. The findings are:
A. Record review of Physician's orders dated 11/20/23 indicated the following order. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction